This drug entry is a stub and has not been fully annotated. It is scheduled to be annotated soon.

Identification

Generic Name
Aluminum cation
DrugBank Accession Number
DB14519
Background

Not Available

Type
Small Molecule
Groups
Experimental
Structure
Weight
Average: 26.9815
Monoisotopic: 26.981538441
Chemical Formula
Al
Synonyms
  • Aluminium, ion (Al3+)
  • Aluminum(3+)
  • Aluminum(III)
  • Aluminum(III) ion
  • Alumunum ion

Pharmacology

Indication

Not Available

Reduce drug development failure rates
Build, train, & validate machine-learning models
with evidence-based and structured datasets.
See how
Build, train, & validate predictive machine-learning models with structured datasets.
See how
Contraindications & Blackbox Warnings
Avoid life-threatening adverse drug events
Improve clinical decision support with information on contraindications & blackbox warnings, population restrictions, harmful risks, & more.
Learn more
Avoid life-threatening adverse drug events & improve clinical decision support.
Learn more
Pharmacodynamics

Not Available

Mechanism of action
Not Available
Absorption

Not Available

Volume of distribution

Not Available

Protein binding

Not Available

Metabolism
Not Available
Route of elimination

Not Available

Half-life

Not Available

Clearance

Not Available

Adverse Effects
Improve decision support & research outcomes
With structured adverse effects data, including: blackbox warnings, adverse reactions, warning & precautions, & incidence rates.
Learn more
Improve decision support & research outcomes with our structured adverse effects data.
Learn more
Toxicity

Not Available

Pathways
Not Available
Pharmacogenomic Effects/ADRs
Not Available

Interactions

Drug Interactions
This information should not be interpreted without the help of a healthcare provider. If you believe you are experiencing an interaction, contact a healthcare provider immediately. The absence of an interaction does not necessarily mean no interactions exist.
DrugInteraction
CabotegravirThe serum concentration of Cabotegravir can be decreased when it is combined with Aluminum cation.
DeferiproneAluminum cation can cause a decrease in the absorption of Deferiprone resulting in a reduced serum concentration and potentially a decrease in efficacy.
DolutegravirThe serum concentration of Dolutegravir can be decreased when it is combined with Aluminum cation.
RaltegravirThe serum concentration of Raltegravir can be decreased when it is combined with Aluminum cation.
Identify potential medication risks
Easily compare up to 40 drugs with our drug interaction checker.
Get severity rating, description, and management advice.
Learn more
Food Interactions
Not Available

Categories

Drug Categories
Chemical TaxonomyProvided by Classyfire
Description
This compound belongs to the class of inorganic compounds known as homogeneous post-transition metal compounds. These are inorganic compounds containing only metal atoms,with the largest atom being a post-transition metal atom.
Kingdom
Inorganic compounds
Super Class
Homogeneous metal compounds
Class
Homogeneous post-transition metal compounds
Sub Class
Not Available
Direct Parent
Homogeneous post-transition metal compounds
Alternative Parents
Not Available
Substituents
Homogeneous post-transition metal
Molecular Framework
Not Available
External Descriptors
monoatomic aluminium, monoatomic trication, aluminium cation (CHEBI:49470) / a cation (CPD-1484)
Affected organisms
Not Available

Chemical Identifiers

UNII
3XHB1D032B
CAS number
22537-23-1
InChI Key
REDXJYDRNCIFBQ-UHFFFAOYSA-N
InChI
InChI=1S/Al/q+3
IUPAC Name
aluminium(3+) ion
SMILES
[Al+3]

References

General References
Not Available
ChemSpider
94544
RxNav
1546162
ChEBI
49470
PDBe Ligand
AL
PDB Entries
1xlg / 1xlh / 1xlm / 2d3i / 6jim / 7voj / 7vq7

Clinical Trials

Clinical Trials
PhaseStatusPurposeConditionsCount

Pharmacoeconomics

Manufacturers
Not Available
Packagers
Not Available
Dosage Forms
Not Available
Prices
Not Available
Patents
Not Available

Properties

State
Not Available
Experimental Properties
Not Available
Predicted Properties
PropertyValueSource
logP1.45Chemaxon
pKa (Strongest Acidic)4.07Chemaxon
Physiological Charge3Chemaxon
Hydrogen Acceptor Count0Chemaxon
Hydrogen Donor Count0Chemaxon
Polar Surface Area0 Å2Chemaxon
Rotatable Bond Count0Chemaxon
Refractivity0 m3·mol-1Chemaxon
Polarizability1.78 Å3Chemaxon
Number of Rings0Chemaxon
Bioavailability1Chemaxon
Rule of FiveYesChemaxon
Ghose FilterNoChemaxon
Veber's RuleYesChemaxon
MDDR-like RuleNoChemaxon
Predicted ADMET Features
Not Available

Spectra

Mass Spec (NIST)
Not Available
Spectra
Not Available

Drug created at July 12, 2018 16:44 / Updated at June 12, 2020 16:53